Versant Capital Management, Inc Bausch Health Companies Inc. Transaction History

Versant Capital Management, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	BUY	$7.06 - $23.63 $353 - $1,181	50 New	50 $0
Q2 2019 Jul 16, 2019	SELL	$20.52 - $26.45 $430 - $555	-21 Closed	0 $0
Q1 2019 Apr 23, 2019	BUY	$20.23 - $26.29 $424 - $552	21 New	21 $0
Q1 2019 Apr 23, 2019	SELL	$20.23 - $26.29 $424 - $552	-21 Closed	0 $0
Q3 2018 Oct 15, 2018	BUY	$20.64 - $25.67 $433 - $539	21 New	21 $0

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Versant Capital Management, Inc with notifications on news.